EMPAGLIFLOZIN (EMPA) REDUCES MORTALITY IN ANALYSES ADJUSTED FOR CONTROL OF BLOOD PRESSURE (BP), LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) AND HBA1C OVER TIME
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI